Jointechlabs, Inc.

Headquartered in Brandon, FL, privately-held Jointechlabs is an emerging worldwide leader in regenerative medicine.

The company enables healthcare practitioners to provide safe, cost-effective, non-surgical therapies at the point-of-care without change in infrastructure.

FDA-cleared MiniTC® is a stand-alone device for processing autologous fat into regenerative-cell-rich microfat. Microfat’s uses include a variety of orthopedic, aesthetic, wound healing, and reconstructive surgery applications. Additionally, in certain markets, CE-Mark-approved Mini-Stem System® extracts microfat and Stromal Vascular Fraction. Pipeline includes development of stem-cell based therapeutics with 3D Bioprinted constructs and injectable stem cell scaffolding.

Posts attributed to Jointechlabs may have been written by one or more staff members, consultants, or third parties.

More Information: https://www.jointechlabs.com.

Home Page: https://jointechlabs.com

Posts by Jointechlabs, Inc.

Jointechlabs Names Dr. George A. Skarpas Scientific Clinical Lead for EU Clinical Studies
Jointechlabs appoints respected doctor and surgeon George A. Karpas to a new post as scientific clinical lead for EU studies.
First Commercial Use of Jointechlabs’ Mini-Stem System in Italy, Greece, and Cyprus
Jointechlabs announced the first successful use of its groundbreaking medical device, Mini-Stem System® , in Italy, Greece, and Cyprus.
Jointechlabs Secures CE Mark Approval for Mini-Stem System in Europe, Will Soon Launch Regenerative Medicine Product
Mini-Stem System has received CE Mark approval
Dr. Nathan Katz Adipose Seminar at TOBI
Excerpts from a presentation by Dr. Nathan Katz, CEO of Jointechlabs, to The Orthobiologic Insititute, on August 14, 2024.
Jointechlabs Adds Orthopedic and Aesthetic Depth to Scientific Advisory Board
Renowned doctors Dr. William D. Murrell (orthopedics) and Dr. Carlos Mercado (aesthetics) bring new scientific and market savvy to the company.
When BMAC (Bone Marrow) Isn’t Indicated, Microfat May Be!
BMAC and microfat both provide orthopedic advantages. Microfat can also be used when BMAC is not indicated.
Jointechlabs’ CEO on “Talk is Biotech”
“Join us on the Talk is Biotech! podcast as we chat with Nathan Katz about his incredible journey from completing his PhD to becoming a medical scientist and ultimately a successful CEO of Jointechlabs, Inc.”
Joint Venture and Patent Grant Mark Jointechlabs’ Entry Into China Regenerative Medicine Microfat Market
Jointechlabs has been granted a core Chinese patent and has entered into a joint venture to develop the microfat market in China.
Best Practices Adipose Presentation for Practitioners
Dr. Nathan Katz discusses best practices in microfat-based procedures and the processing of microfat for optimal results.
Jointechlabs Makes Microfat-based Regenerative Medical Procedures More Efficient and Profitable
Jointechlabs has released new components and standardized processing to reduce time, complexity, and cost of microfat-based regenerative medicine procedures.